Showing 981 - 1,000 results of 1,475 for search '"cancer"', query time: 0.09s Refine Results
  1. 981

    Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells by Marta Buzzetti, Sonia Morlando, Dimitrios Solomos, Ammara Mehmood, Alexander W. I. Cox, Mattia Chiesa, Yuri D’Alessandra, Michela Garofalo, Caroline H. Topham, Gianpiero Di Leva

    Published 2021-03-01
    “…Cyclin Dependent Kinase inhibitors (CDKi) are at the front-line of novel targeted treatments for multiple cancers and the CDK4/6 specific inhibitor palbociclib has been pre-clinically identified as an effective option for MB cells. …”
    Get full text
    Article
  2. 982

    Results of long-term follow-up of patients with chronic gastritis after <i>H. pylori</i> eradication by T. L. Lapina, A. S. Tertychny, E. R. Nasretdinova, I. M. Kartavenko, A. V. Paraskevova, Ye. Yu. Yur’yeva, O. A. Storonova, A. S. Trukhmanov, V. T. Ivashkin

    Published 2015-09-01
    “…To analyze approach for long-term management of patients with chronic gastritis after H. pylori eradication for stomach cancer prevention by the example of clinical cases.Key points. …”
    Get full text
    Article
  3. 983
  4. 984

    Autoimmune gastritis pathogenesis and risk factors of stomach malignant neoplasia by Ye. A. Losik, V. T. Ivashkin

    Published 2015-09-01
    “…To demonstrate possible pathways of development of stomach malignant neoplasias at autoimmune gastritis.Key points. Stomach cancer traditionally occupies one of the first places within oncologic diseases in the world. …”
    Get full text
    Article
  5. 985
  6. 986
  7. 987
  8. 988
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993

    Mycochemistry, antioxidant, anticancer activity, and molecular docking of compounds of F12 of ethyl acetate extract of Astraeus asiaticus with BcL2 and Caspase 3 by Swapan Kumar Ghosh, Koushik Pandey, Madhuparna Ghosh, Pradip Kumar Sur

    Published 2025-02-01
    “…Abstract Globally the current research is going for cancer disease management by different strategies as frequency and severity of this disease are increasing day by day. …”
    Get full text
    Article
  14. 994

    Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia by Benjamin M. Heyman, Stephen S. Opat, Björn E. Wahlin, Meletios-Athanasios C. Dimopoulos, Jorge J. Castillo, Alessandra Tedeschi, Constantine S. Tam, Christian Buske, Roger G. Owen, Véronique Leblond, Judith Trotman, Gisoo Barnes, Wai Y. Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Jeffrey V. Matous

    Published 2025-02-01
    “…Health-related quality of life (HRQOL) was assessed using the validated European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30. Forty-nine patients with PN symptoms were included (zanubrutinib treated, n = 27; ibrutinib treated, n = 22). …”
    Get full text
    Article
  15. 995

    Ulcerative colitis: STRIDE-ing beyond symptoms with new standards by Shu Wen Tay, Kevin Kim Jun Teh, Tiing-Leong Ang, Malcolm Tan

    Published 2024-02-01
    “…Controlling the burden of disease activity also lowers the risk of developing colorectal cancer. Colorectal cancer screening now requires the use of dye-based agents and high-definition colonoscopy to improve the detection of colonic neoplasms.…”
    Get full text
    Article
  16. 996

    Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma by JinSong Li, GuanBo Zhang, Gang Li, Jie Zhang, Zhi Yang, Lin Yang, ShiJie Jiang, JiaXing Wang

    Published 2025-02-01
    “…Abstract Hepatocellular carcinoma (HCC) is one of the most prevalent cancers, characterized by high morbidity and mortality rates. …”
    Get full text
    Article
  17. 997

    Colony-Forming and Cell Viability Assay to Assess Nanotoxicity of Maleic Acid and N-vinyl Caprolactam-Based Nanoarchitectures by Bekar Buse, Akar Burcu, Akan Handan Sevim, Can Hatice Kaplan

    Published 2025-01-01
    “…Nanocomposites significantly inhibited colony formation in both cancer cell lines, particularly in the HeLa cell line. …”
    Get full text
    Article
  18. 998

    Integrative analysis of SEPN1 in glioma: Prognostic roles, functional implications, and potential therapeutic interventions. by Zisong Wang, Danwen Wang, Xuanyu Wang, Yihang Xu, Yunhe Yuan, Yuxin Chen, Zhiqiang Li, Xiaoping Liu

    Published 2025-01-01
    “…<h4>Background</h4>SEPN1, a selenoprotein involved in redox regulation and endoplasmic reticulum stress response, has an unclear role in cancer. This study aims to investigate the expression, prognostic significance, and tumor microenvironment (TME) relevance of SEPN1 across pan-cancer, with a particular focus on glioma.…”
    Get full text
    Article
  19. 999

    Comparison of Frozen and Final Pathology Results in Patients Operated for Endometrial Hyperplasia by Gonca Turker Ergun, Ugurcan Zorlu, Burak Elmas, Bengü Nur Baris Akcan, Gul Kurtaran, Kadir Cetinkaya, Melike Doganay

    Published 2024-12-01
    “… OBJECTIVE: Our study aimed to determine the frequency of endometrial cancer in patients undergoing surgery with a diagnosis of endometrial hyperplasia and to evaluate the concordance between preoperative diagnosis, frozen section examination, and final pathology results. …”
    Get full text
    Article
  20. 1000

    Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis by Xiaofan Sun, Yue Li, Juan Du, Fangshu Liu, Caiping Wu, Weihao Xiao, Guopan Yu, Xiaowei Chen, Robert Peter Gale, Hui Zeng

    Published 2025-02-01
    “…Abstract Sphingolipid, ceramide for example, plays an essential role in regulating cancer cell death. Defects in the generation and metabolism of ceramide in cancer cells contribute to tumor cell survival and resistance to chemotherapy. …”
    Get full text
    Article